Vital Signs - Reform for Orthopedics  Healthcare Reforms Effect on the Orthopedic Market

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on September 14, 2009, provides a strategic overview of the potential impact of U.S. Congressional bill H.R.
3200, America’s Affordable Health Choices Act, on U.S. healthcare and the orthopedic market. Additionally, a company spotlight is provided for Pepex Biomedical a company specialized in developing, manufacturing, and marketing miniature, disposable, electrochemical biosensors. Reimbursement and regulatory news from the FDA is also provided for the week of August 31, 2009.

Table of Contents

Vital Signs - Reform for Orthopedics – Healthcare Reform’s Effect on the Orthopedic MarketVital Signs:14 September 2009This week's issue:




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.